I see that Carmine Zingarino is still pumping this company.
Proceedings of the American Society of Clinical Oncology (ASCO)
Thirty-Second Annual Meeting - May 18-21, 1996
Philadelphia, Pennsylvania
INDUCTION OF DIFFERENTIATION AND APOPTOSIS OF U937 AND HL-60 CELLS BY
ONCONASE: POTENTIATION BY INHIBITORS OF PROTEIN KINASES.
H.D. Halicka(1), B. Ardelt(1), A. Mittelman(1), W. Ardelt(2), S. Mikulski(2),
K. Shogen(2) and Z. Darzynkiewicz(1). (1)New York Medical College, Valhalla,
N.Y., 10595; (2)Alfacell Corp., Bloomfield, N.J., 07003.
An ASCO abstract isn't exactly difficult to get published, you realize. As usual, this is a company-sponsored publication, and, again as usual, it deals with in vitro results. I don't know a single scientist (or analyst) who takes this company seriously.
Rick |
